Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for March 2026

Showing all data including statistical outliers.Hide Outliers
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Mar 17, 2026
Sale
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Mar 17, 2026
Sale
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Mar 17, 2026
Sale
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Mar 17, 2026
Sale
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Mar 17, 2026
Sale
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Mar 17, 2026
Sale
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Mar 17, 2026
Sale
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Mar 17, 2026
Sale
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Mar 17, 2026
Sale
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Mar 17, 2026
Sale
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Mar 17, 2026
Sale
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Mar 17, 2026
Sale
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Mar 17, 2026
Sale
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Mar 17, 2026
Sale
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%

CytomX Therapeutics, Inc. (CTMX)

BELVIN MARCIA โ€” SVP, Chief Scientific Officer
Mar 17, 2026
Sale
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%
Mar 17, 2026
Purchase
Shares
29,000
Price
$8.60
Total Value
$249.37K
Shares Held After
350,000
% of Holdings
8.3%
Mar 17, 2026
Sale
Shares
141
Price
$155.00
Total Value
$21.86K
Shares Held After
0
% of Holdings
100.0%
Mar 17, 2026
Sale
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Mar 17, 2026
Sale
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Mar 17, 2026
Sale
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Mar 17, 2026
Sale
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Mar 17, 2026
Sale
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Mar 17, 2026
Sale
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Mar 17, 2026
Sale
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Mar 17, 2026
Sale
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Mar 17, 2026
Sale
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Mar 17, 2026
Sale
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Mar 17, 2026
Sale
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Mar 17, 2026
Sale
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Mar 17, 2026
Sale
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Mar 17, 2026
Sale
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%
Mar 17, 2026
Sale
Shares
38,864
Price
$14.47
Total Value
$562.35K
Shares Held After
1,007,277
% of Holdings
3.7%

Roivant Sciences Ltd. (ROIV)

Venker Eric โ€” President & Immunovant CEO
Mar 17, 2026
Sale
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
75
Price
$159.15
Total Value
$11.94K
Shares Held After
115,113
% of Holdings
0.1%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
1,375
Price
$158.36
Total Value
$217.75K
Shares Held After
115,188
% of Holdings
1.2%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
275
Price
$157.66
Total Value
$43.36K
Shares Held After
116,563
% of Holdings
0.2%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
1,575
Price
$156.33
Total Value
$246.21K
Shares Held After
116,838
% of Holdings
1.3%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
1,704
Price
$155.00
Total Value
$264.12K
Shares Held After
118,413
% of Holdings
1.4%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
1,484
Price
$153.91
Total Value
$228.40K
Shares Held After
120,117
% of Holdings
1.2%

CRA INTERNATIONAL, INC. (CRAI)

Maleh Paul A โ€” Director
Mar 17, 2026
Sale
Shares
1,012
Price
$152.66
Total Value
$154.49K
Shares Held After
121,601
% of Holdings
0.8%
Mar 17, 2026
Sale
Shares
3,938
Price
$11.23
Total Value
$44.22K
Shares Held After
3,956,368
% of Holdings
0.1%

Enliven Therapeutics, Inc. (ELVN)

Collins Helen Louise โ€” CHIEF MEDICAL OFFICER
Mar 17, 2026
Sale
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Mar 17, 2026
Sale
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan โ€” GENERAL COUNSEL & CORP SEC
Mar 17, 2026
Sale
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%

Pacira BioSciences, Inc. (PCRX)

SLONIN JONATHAN โ€” Chief Medical Officer
Mar 17, 2026
Sale
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan โ€” GENERAL COUNSEL & CORP SEC
Mar 17, 2026
Sale
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%

Stoke Therapeutics, Inc. (STOK)

Hoitt Jason โ€” Chief Patient Officer
Mar 17, 2026
Sale
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%

Stoke Therapeutics, Inc. (STOK)

Hoitt Jason โ€” Chief Patient Officer
Mar 17, 2026
Sale
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%

Stoke Therapeutics, Inc. (STOK)

Leggett Thomas โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%

Stoke Therapeutics, Inc. (STOK)

Leggett Thomas โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%
Version: v26.3.29